Senate Bill 3353
116th Congress(2019-2020)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Introduced
Introduced in Senate on Feb 27, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3353
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.
Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.
February 27, 2020
02/27/2020
Read twice and referred to the Committee on Finance.
02/27/2020
Introduced in Senate
Public Record
Record Updated
Feb 8, 2022 11:22:59 PM